GENinCode Plc 9PL.F Stock
GENinCode Plc Price Chart
GENinCode Plc 9PL.F Financial and Trading Overview
| GENinCode Plc stock price | 0.09 EUR |
| Previous Close | 0.15 EUR |
| Open | 0.14 EUR |
| Bid | 0.14 EUR x N/A |
| Ask | 0.16 EUR x N/A |
| Day's Range | 0.14 - 0.14 EUR |
| 52 Week Range | 0.08 - 0.27 EUR |
| Volume | 200 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 14.48M EUR |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.08 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
9PL.F Valuation Measures
| Enterprise Value | 4.42M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 10.128737 |
| Price/Book (mrq) | 1.7560974 |
| Enterprise Value/Revenue | 3.091 |
| Enterprise Value/EBITDA | -0.771 |
Trading Information
GENinCode Plc Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -35.13% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.27 EUR |
| 52 Week Low | 0.08 EUR |
| 50-Day Moving Average | 0.17 EUR |
| 200-Day Moving Average | 0.17 EUR |
9PL.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 95.82M |
| Float | 36.45M |
| Short Ratio | N/A |
| % Held by Insiders | 45.16% |
| % Held by Institutions | 33.95% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -412.51% |
| Gross Margin | 44.19% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -27.30% |
| Return on Equity (ttm) | -51.42% |
Income Statement
| Revenue (ttm) | 1.43M EUR |
| Revenue Per Share (ttm) | 0.02 EUR |
| Quarterly Revenue Growth (yoy) | 38.20% |
| Gross Profit (ttm) | N/A |
| EBITDA | -5736000 EUR |
| Net Income Avi to Common (ttm) | -5559000 EUR |
| Diluted EPS (ttm) | -0.06 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 9.73M EUR |
| Total Cash Per Share (mrq) | 0.1 EUR |
| Total Debt (mrq) | 354K EUR |
| Total Debt/Equity (mrq) | 4.48 EUR |
| Current Ratio (mrq) | 4.814 |
| Book Value Per Share (mrq) | 0.082 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -3762000 EUR |
| Levered Free Cash Flow (ttm) | -3372000 EUR |
Profile of GENinCode Plc
| Country | Germany |
| State | N/A |
| City | Manchester |
| Address | One St Peters Square |
| ZIP | M2 3DE |
| Phone | N/A |
| Website | https://www.genincode.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 35 |
GENinCode Plc develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient's health based on their genes in the United Kingdom and internationally. Its predictive technology provides patients and physicians with preventative care and treatment strategies. The company's molecular tests combine clinical algorithms and artificial intelligence to provide advanced patient risk assessment to predict disease onset. Its tests include Cardio inCode, a patented genetic test to help user to adopt cardiovascular prevention steps; Lipid inCode, a genetic diagnostic test for familial hypercholesterolemia; SUDD inCode, a genetic test to diagnose the cause of sudden cardiac death and familial heart disease; Thrombo inCode, a genetic test for diagnosis of hereditary thrombophilia and the risk of thrombosis; and Thrombo inCode Reproductive Health, a genetic test that offers information related to risk of thrombophilia and associated risks for future pregnancies. GENinCode Plc was incorporated in 2018 and is based in Manchester, the United Kingdom.
Q&A For GENinCode Plc Stock
What is a current 9PL.F stock price?
GENinCode Plc 9PL.F stock price today per share is 0.09 EUR.
How to purchase GENinCode Plc stock?
You can buy 9PL.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for GENinCode Plc?
The stock symbol or ticker of GENinCode Plc is 9PL.F.
Which industry does the GENinCode Plc company belong to?
The GENinCode Plc industry is Diagnostics & Research.
How many shares does GENinCode Plc have in circulation?
The max supply of GENinCode Plc shares is 185.58M.
What is GENinCode Plc Price to Earnings Ratio (PE Ratio)?
GENinCode Plc PE Ratio is now.
What was GENinCode Plc earnings per share over the trailing 12 months (TTM)?
GENinCode Plc EPS is -0.08 EUR over the trailing 12 months.
Which sector does the GENinCode Plc company belong to?
The GENinCode Plc sector is Healthcare.